Sttr phase i: standardized and reproducible culture and activation of endothelial cells in microfluidic devices for drug screening applications
Ended Project Grant Awarded Last action
- Award ID
- 2112202
- Recipient
-
Biochip Labs Inc. UEI K5TKCGKKA1T9
- Awarding agency
-
Division of Industrial Innovation
National Science Foundation
- Obligated
- $256,000
Award facts
- Assistance listing
- 47.041 Engineering
- Completion date
- Originally
- Funding agency
- National Science Foundation
- Place of performance
- Cleveland, OH 44103, USA
Award details come from USAspending.gov.
About this award
Biochip Labs Inc. received a $256,000 National Science Foundation Project Grant under the Engineering program (CFDA 47.041) for the period of June 1, 2021 through May 31, 2022. The grant funding supports the company's work to develop standardized and reproducible culture and activation methods for endothelial cells in microfluidic devices for drug screening applications. The NSF Engineering program seeks to improve quality of life and economic strength through engineering research and innovation. This award will help advance Biochip Labs' product development efforts in microfluidic cell culture technologies with potential downstream applications in pharmaceutical research and development.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $256,000 |
Quick answers
Who received award 2112202?
2112202 was awarded to Biochip Labs Inc. by Division of Industrial Innovation (National Science Foundation) on June 1, 2021.
How much is award 2112202 worth?
$256,000 has been obligated on 2112202.
Which agency awarded 2112202?
Division of Industrial Innovation (National Science Foundation) awarded 2112202, with funding from National Science Foundation.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award